Back to Editor profile » Dr Dana Kristjansson
Dr Dana Kristjansson
Dr Dana Kristjansson
Department of Genetics and Bioinformatics / Center of Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway
Dana Kristjansson, MD, PhD is an internationally trained cancer epidemiologist with an extensive background in register-based epidemiology, cancer epidemiology, fertility, and mitochondrial DNA studies. Currently a Senior Scientist at the Norwegian Institute of Public Health, Dr. Kristjansson leads a project on cancer within the Mother, Father, and Child Cohort Study and holds the role of Specialty Chief Editor of Frontiers in Oncology's section on Cancer Epidemiology and Prevention.
Dr. Kristjansson was previously a resident in Internal Medicine at New York-Presbyterian Healthcare. She has held research positions at institutions like Mount Sinai Hospital, Columbia University Medical Center, and the WHO's International Agency for Research on Cancer. Her ongoing efforts also extend to mentoring and teaching, notably at the Icahn School of Medicine at Mount Sinai and Georgetown University, and she has contributed significantly to public health awareness through media coverage and blog posts. Her work has been featured in outlets such as the Centers for Disease Control and Prevention (CDC), National Public Radio (NPR), and Reuters, among others.
Updated 10 February 2025
